Sharp Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	66	30	-	-
Enterprise Value	65	50	-	-
Last Close Price	2.20	1.05	1.05	-
PB Ratio	33.55	7.97	-	-
P/TBV Ratio	33.55	7.97	-	-
Debt / Equity Ratio	0.91	0.51	-1.10	-1.15
Quick Ratio	4.62	5.05	0.05	0.04
Current Ratio	4.80	5.10	0.06	0.05
Return on Assets (ROA)	-	-52.06%	-95.55%	-
Return on Capital Employed (ROCE)	-150.50%	-65.80%	36.70%	86.80%
Earnings Yield	-7.00%	-15.83%	-	-
FCF Yield	-	-17.63%	-	-
Buyback Yield / Dilution	-1300.62%	-107.12%	-3028.62%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.